DK0989121T3 - Substituerede benzamider og deres anvendelse som immunmodulatorer - Google Patents

Substituerede benzamider og deres anvendelse som immunmodulatorer

Info

Publication number
DK0989121T3
DK0989121T3 DK99117319T DK99117319T DK0989121T3 DK 0989121 T3 DK0989121 T3 DK 0989121T3 DK 99117319 T DK99117319 T DK 99117319T DK 99117319 T DK99117319 T DK 99117319T DK 0989121 T3 DK0989121 T3 DK 0989121T3
Authority
DK
Denmark
Prior art keywords
immunomodulators
substituted benzamides
benzamides
substituted
Prior art date
Application number
DK99117319T
Other languages
Danish (da)
English (en)
Inventor
Oswald Dr Zimmer
Tieno Dr Germann
Stefanie Dr Frosch
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK0989121T3 publication Critical patent/DK0989121T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/94Oxygen atom, e.g. piperidine N-oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • C07D211/88Oxygen atoms attached in positions 2 and 6, e.g. glutarimide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK99117319T 1998-09-24 1999-09-03 Substituerede benzamider og deres anvendelse som immunmodulatorer DK0989121T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843793A DE19843793C2 (de) 1998-09-24 1998-09-24 Substituierte Benzamide

Publications (1)

Publication Number Publication Date
DK0989121T3 true DK0989121T3 (da) 2005-12-12

Family

ID=7882078

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99117319T DK0989121T3 (da) 1998-09-24 1999-09-03 Substituerede benzamider og deres anvendelse som immunmodulatorer

Country Status (27)

Country Link
US (1) US6080742A (hu)
EP (1) EP0989121B1 (hu)
JP (1) JP2000095761A (hu)
KR (1) KR20000023339A (hu)
CN (1) CN1126741C (hu)
AR (1) AR021814A1 (hu)
AT (1) ATE309987T1 (hu)
AU (1) AU750919B2 (hu)
BR (1) BR9906070A (hu)
CA (1) CA2283021A1 (hu)
CO (1) CO5160263A1 (hu)
CZ (1) CZ295496B6 (hu)
DE (2) DE19843793C2 (hu)
DK (1) DK0989121T3 (hu)
ES (1) ES2251143T3 (hu)
HK (1) HK1026211A1 (hu)
HU (1) HUP9903216A3 (hu)
IL (1) IL132012A (hu)
NO (1) NO312671B1 (hu)
NZ (1) NZ337531A (hu)
PE (1) PE20001050A1 (hu)
PL (1) PL194897B1 (hu)
RU (1) RU2221783C2 (hu)
SI (1) SI0989121T1 (hu)
SK (1) SK283316B6 (hu)
UY (1) UY25712A1 (hu)
ZA (1) ZA996133B (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10002509A1 (de) 2000-01-21 2001-07-26 Gruenenthal Gmbh Substituierte Glutarimide
WO2001070688A2 (de) * 2000-03-20 2001-09-27 Grünenthal GmbH N-(2,6-dioxo-piperidin-3-yl) benzamide und ihre verwendung als immunomodulatoren
US20050226845A1 (en) * 2004-03-10 2005-10-13 Chih-Ping Liu Method of treatment using interferon-tau
US7431920B2 (en) * 2000-07-19 2008-10-07 Pepgen Corporation Method of treating IL-10 deficiency
US20050118138A1 (en) * 2000-07-19 2005-06-02 Chih-Ping Liu Method of treatment using interferon-tau
US20050201981A1 (en) * 2004-03-10 2005-09-15 Chih-Ping Liu Method of optimizing treatment with interferon-tau
US20050084478A1 (en) * 2000-10-17 2005-04-21 Chih-Ping Liu Combination therapy using interferon-tau
US20040247565A1 (en) * 2000-07-19 2004-12-09 Chih-Ping Liu Method of treatment using interferon-tau
US20050118137A1 (en) * 2000-07-19 2005-06-02 Chih-Ping Liu Method of treatment using interferon-tau
EP1199074A1 (en) * 2000-09-15 2002-04-24 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production
EP1188438A1 (en) * 2000-09-15 2002-03-20 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production
ES2338534T3 (es) * 2001-02-27 2010-05-10 The Governement Of The Usa, Represented By The Secretary Department Of Health And Human Services Analogos de talidomina como inhibidores de la angiogenesis.
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
WO2003037365A1 (en) * 2001-11-01 2003-05-08 The Johns Hopkins University Methods and compositions for treating vascular leak using hepatocyte growth factor
DE10163595A1 (de) * 2001-12-21 2003-08-07 Gruenenthal Gmbh In 3-Position heterocyclisch substituierte Piperidin-2,6-dione
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
CN1867331B (zh) 2003-09-17 2010-05-26 美国政府健康及人类服务部 作为TNF-α调节剂的沙利度胺类似物
US20060078942A1 (en) * 2004-03-10 2006-04-13 Pepgen Corporation Method of treatment using interferon-tau
US20080025948A1 (en) * 2004-03-10 2008-01-31 Chih-Ping Liu Methods of Treatment Using Interferon-Tau
DE102004026703A1 (de) * 2004-05-28 2005-12-29 Grünenthal GmbH Verfahren zur Herstellung von in 3-Position heterocyclisch substituierten Piperidin-2,6-dionen
AU2007238785B2 (en) * 2006-04-13 2013-02-07 Agnieszka Ambrozak Tetrahalogenated compounds useful as inhibitors of angiogenesis
US8314107B2 (en) 2008-04-23 2012-11-20 Rigel Pharmaceuticals, Inc. Carboxamide compounds and methods for using the same
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds
KR102316961B1 (ko) * 2020-01-29 2021-10-26 프라비바이오 주식회사 면역억제제로서의 벤젠 유도체의 면역억제용 약학적 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545672B2 (de) * 1965-05-08 1974-11-07 Chemie Gruenenthal Gmbh, 5190 Stolberg Dikarbonsäureimidderivate und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
ZA996133B (en) 2000-04-06
AU750919B2 (en) 2002-08-01
DE59912795D1 (de) 2005-12-22
NO312671B1 (no) 2002-06-17
CZ338699A3 (cs) 2000-08-16
CA2283021A1 (en) 2000-03-24
ES2251143T3 (es) 2006-04-16
PL194897B1 (pl) 2007-07-31
HK1026211A1 (en) 2000-12-08
IL132012A (en) 2004-02-19
AR021814A1 (es) 2002-08-07
PE20001050A1 (es) 2000-11-18
UY25712A1 (es) 2001-05-31
KR20000023339A (ko) 2000-04-25
NO994626D0 (no) 1999-09-23
JP2000095761A (ja) 2000-04-04
RU2221783C2 (ru) 2004-01-20
CO5160263A1 (es) 2002-05-30
BR9906070A (pt) 2000-08-15
DE19843793C2 (de) 2000-08-03
CN1250048A (zh) 2000-04-12
IL132012A0 (en) 2001-03-19
DE19843793A1 (de) 2000-04-20
US6080742A (en) 2000-06-27
SI0989121T1 (sl) 2006-04-30
SK130899A3 (en) 2000-06-12
SK283316B6 (sk) 2003-05-02
HUP9903216A3 (en) 2000-10-30
EP0989121B1 (de) 2005-11-16
EP0989121A1 (de) 2000-03-29
PL335555A1 (en) 2000-03-27
CZ295496B6 (cs) 2005-08-17
HUP9903216A2 (hu) 2000-06-28
ATE309987T1 (de) 2005-12-15
AU4886199A (en) 2000-03-30
CN1126741C (zh) 2003-11-05
NZ337531A (en) 2000-09-29
NO994626L (no) 2000-03-27
HU9903216D0 (en) 1999-11-29

Similar Documents

Publication Publication Date Title
DK0989121T3 (da) Substituerede benzamider og deres anvendelse som immunmodulatorer
NO991922L (no) Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer
DK1246802T3 (da) 4-aminopicolinater og deres anvendelse som herbicider
DK1345918T3 (da) 1,5-benzothiazepiner og deres anvendelse som antihyperlipidæmiske midler
NO20020383L (no) Mutilinderivater og deres anvendelse som anti-bakterielle midler
DK1133477T3 (da) Substituerede benzimidazoler og deres anvendelse som parpinhibitorer
NO20014135L (no) Nye sulfonamidforbindelser og deres anvendelse
NO972983D0 (no) Sulfonamider og deres anvendelse
NO20005265L (no) Substituerte benzamider, deres fremstilling og anvendelse som inhibitorer av cystin-proteaser
NO992492D0 (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
NO20033566L (no) Acylerte 6,7,8,9-tetrehydro-5H-benzocykloheptenyl-aminer og deres anvendelse som farmasöytiske midler
NO20021253L (no) Kinolylpropylpiperidinderivater og deres anvendelse som antibakterielle midler
NO20011956D0 (no) Substituerte fenylderivater, deres fremstilling og anvendelse
NO20025357L (no) Antranylamider og deres anvendelse som legemidler
NO20005146D0 (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
DK1012137T3 (da) Aromatiske C-16-C-20-substituerede tetrahydro-prostaglandiner og deres anvendelse som prostaglandin FP-agonister
NO20042719L (no) Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer
NO984761D0 (no) Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler
NO994510D0 (no) Substituerte isokinolin-derivater og deres anvendelse som antikonvulsanter
NO995513L (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
NO985891D0 (no) Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler
DK1214302T3 (da) Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere
NO20023951D0 (no) Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler
NO20013085D0 (no) Fosfororganiske forbindelser og deres anvendelse